StockData
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23

Orthofix Medical Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$9.59+0.21 (+2.24%)

Close on Oct 19, 2026

Market cap
$392.29M
P/E (TTM)
–
Dividend yield
–

Orthofix Medical statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison

Valuation

MeasureOrthofix MedicalIndustry median
Market Cap$390.63M$230.55M
Enterprise Value$508.41M$202.97M
PS Ratio0.473.11
PB Ratio0.913.14
P/TBV Ratio2.324.57
P/OCF Ratio24.0222.35

Enterprise value

MeasureOrthofix MedicalIndustry median
EV / Sales0.612.92
EV / EBITDA37.2119.86

Income (trailing twelve months)

MeasureOrthofix MedicalIndustry median
Revenue$833.19M$102.39M
Gross Profit$594.12M$60.36M
Operating Income-$39.12M-$4.31M
Pretax Income-$60.29M-$2.26M
Net Income-$61.72M-$6.57M
EBITDA$13.66M-$1.98M
EPS (Diluted)-$1.54-$0.07

Margins

MeasureOrthofix MedicalIndustry median
Gross Margin71.3%55.1%
Operating Margin-4.70%-6.04%
Pretax Margin-7.24%-4.11%
Profit Margin-7.41%-10.5%
EBITDA Margin1.64%-2.67%
FCF Margin-3.34%-0.30%

Returns

MeasureOrthofix MedicalIndustry median
Return on Equity (ROE)-13.9%-19.2%
Return on Assets (ROA)-7.22%-13.3%
Return on Invested Capital (ROIC)-5.64%-4.11%
Return on Capital Employed (ROCE)-5.46%-9.07%

Growth

MeasureOrthofix MedicalIndustry median
Revenue Growth (YoY)2.99%8.85%
FCF Growth (YoY)-6135.6%10.6%
Revenue Growth (3Y CAGR)21.3%7.08%
Revenue Growth (5Y CAGR)15.1%11.8%

Balance sheet

MeasureOrthofix MedicalIndustry median
Cash & Short-Term Investments$103.81M$37.33M
Total Debt$221.59M$72.66M
Net Cash (Debt)-$117.78M$3.92M
Net Cash Per Share-$2.89$0.28
Equity (Book Value)$429.18M$57.36M
Book Value Per Share$10.54$2.81
Tangible Book Value$168.27M$10.71M
Working Capital$289.12M$54.64M

Financial position

MeasureOrthofix MedicalIndustry median
Current Ratio2.842.50
Quick Ratio1.531.54
Debt / Equity0.520.38
Debt / EBITDA16.222.31
Net Debt / EBITDA8.621.53

Cash flow (trailing twelve months)

MeasureOrthofix MedicalIndustry median
Operating Cash Flow$16.27M-$653.46K
Capital Expenditures-$44.09M-$3.69M
Free Cash Flow-$27.82M-$835.02K
FCF Per Share-$0.68-$0.02

Efficiency

MeasureOrthofix MedicalIndustry median
Asset Turnover0.970.59
Inventory Turnover1.342.21
Revenue Per Employee$519.12K$322.57K
Profits Per Employee-$38.46K-$51.88K
Employee Count1,605185

Dividends and yields

MeasureOrthofix MedicalIndustry median
Earnings Yield-15.8%-6.91%
FCF Yield-7.12%-0.56%

Shares

MeasureOrthofix MedicalIndustry median
Shares Outstanding40,732,60044,856,700
Shares Change (YoY)3.36%3.35%
Shares Change (QoQ)0.86%0.27%
Float30,527,40037,097,900
Shares Held by Insiders25.1%10.6%
Shares Held by Institutions94.0%63.5%

Taxes

MeasureOrthofix MedicalIndustry median
Income Tax$1.44M$1.52M

Scores

MeasureOrthofix MedicalIndustry median
Altman Z-Score1.081.95
Piotroski F-Score55
Beneish M-Score-3.21-2.64

Calculated by StockData from Orthofix Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.